Maryland · 2026 Regular Session · Bill

HB 484: Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

In committee Last action January 23, 2026: Hearing 2/12 at 1:00 p.m.

Plain-language summary

HB 484 is a bill introduced in the Maryland House on January 23, 2026. According to its official title, it concerns: Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising. Primary sponsor: Natalie Ziegler (Democratic), Jessica Feldmark (Democratic), Jen Terrasa (Democratic), Jackie Addison (Democratic), Lorig Charkoudian (Democratic), Bonnie Cullison (Democratic), Eric Ebersole (Democratic), Pam Guzzone (Democratic), Terri Hill (Democratic), Gabriel Moreno (Democratic), Courtney Watson (Democratic). Most recent recorded action (January 23, 2026): Hearing 2/12 at 1:00 p.m.

Sponsors

Primary sponsors: Natalie Ziegler (Democratic); Jessica Feldmark (Democratic); Jen Terrasa (Democratic); Jackie Addison (Democratic); and 7 more.